Actívatexto: Advancing Smoking Cessation and Physical Activity Among Latinos

ConditionsSmoking Smoking Cessation Physical Inactivity

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18+

SponsorUniversity of Rochester

About this trial

The purpose of this randomized controlled trial is to assess the efficacy of Actívatexto (Aim 1) and the mediators of the presumed treatment effect (Aim 2) among Latino adults who smoke. Actívatexto is a mobile intervention that integrates four components: 1) a text messaging program that promotes both smoking cessation and physical activity, 2) wearable devices to monitor physical activity, 3) smoking cessation pharmacotherapy \[i.e., nicotine replacement therapies (NRT)\], and 4) an online dashboard where the research team manages participants' incoming and outgoing data from both the text messaging program and wearable devices.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Self-identify as Hispanic and/or Latino

Know how to read and speak English and/or Spanish

Be ≥ 18 years of age

Not meet the recommended levels of physical activity (150 minutes of moderate to vigorous physical activity)

Disqualifiers

Use of tobacco products other than cigarettes in the past 30 days (including e-cigarettes)

Being pregnant or breastfeeding

Plan to move from their current residence in the next six months

Another household member enrolled in the study

Trial design

Design model

Parallel

Treatments tested in this trial

Actívatexto
Behavioral
Actívatexto is a mobile intervention that promotes both smoking cessation and physical activity. Actívatexto integrates four components: 1) a text messaging program that promotes both smoking cessation and physical activity, 2) wearable devices to monitor physical activity, 3) smoking cessation pharmacotherapy (i.e., nicotine replacement therapies), and 4) an online dashboard where the research team manages participants' incoming and outgoing data from both the text messaging program and wearable devices.
Decídetexto
Behavioral
Decídetexto is a mobile intervention that solely promotes smoking cessation. Decídetexto integrates three components: 1) a text messaging program that solely promotes smoking cessation, 2) smoking cessation pharmacotherapy (i.e., nicotine replacement therapies), and 3) an online dashboard where the research team manages participants' incoming and outgoing data from the text messaging program.

Treatment groups

408 Participants

are divided into 2 treatment groups

Group A: ActívatextoExperimental treatment 1 intervention

Group B: DecídetextoActive comparator 1 intervention

Trial outcomes

Primary outcomes

Percent of participants with cotinine verified 7-day point prevalence abstinence

Cotinine levels ≤15 ng/mL in saliva

Time frame

Month 6

Secondary outcomes

Percent of participants with self-reported 7-day point prevalence abstinence

No cigarettes, "not even a puff", in the past 7 days

Time frame

Month 6

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Rochester

Lead sponsor

National Institute on Minority Health and Health Disparities (NIMHD)

Collaborator

Hackensack Meridian Health